FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311495621> ?p ?o ?g. }

• W4311495621 endingPage "1010" @default.
• W4311495621 startingPage "1002" @default.
• W4311495621 abstract "Abstract Aim To investigate changes in the pattern of drugs used to treat type 2 diabetes in Denmark from 2005 to 2021. Materials and Methods A nationwide, population‐based drug utilization study based on medical databases covering the Danish population was conducted. We assessed incident and prevalent use patterns among all 441 205 individuals initiating at least one non‐insulin, glucose‐lowering drug. Results The rate of new users of non‐insulin, glucose‐lowering drugs increased from 2005, peaked in 2011, decreased to stable levels during 2013 to 2019, then increased dramatically during 2020‐2021. The prevalence of use increased from 2.1% (in 2005) to 5.0% (in 2021) of the entire adult population. In 2021, metformin comprised 39% of all glucose‐lowering drug consumption, followed by insulin (17%), sodium‐glucose co‐transporter‐2 inhibitors (SGLT‐2is) (17%), glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) (16%) and dipeptidyl peptidase‐4 inhibitors (7.5%). Overall, 56% of users were on monotherapy, 28% used dual therapy, while 13% and 2.8% used three and four drug classes, respectively. Both the intensity and diversity of therapies increased substantially over time, with 15 different treatment regimens each covering more than 1% of users in 2021. General practitioners prescribed 88% of all glucose‐lowering drugs. Marked shifts towards GLP‐1RA initiation by general practitioners and SGLT‐2i initiation by specialists were observed, and changing user profiles suggested increasing use for non‐diabetes indications. Conclusions The rate of new users of non‐insulin, glucose‐lowering drugs has increased in recent years and the prevalence of glucose‐lowering drug use increases steadily. Glucose‐lowering drugs are mainly prescribed by general practitioners, and the intensity, diversity and indications of glucose‐lowering treatment are increasing." @default.
• W4311495621 created "2022-12-26" @default.
• W4311495621 creator A5004120950 @default.
• W4311495621 creator A5019863081 @default.
• W4311495621 creator A5048966021 @default.
• W4311495621 creator A5059577837 @default.
• W4311495621 creator A5072859924 @default.
• W4311495621 date "2023-01-03" @default.
• W4311495621 modified "2023-10-18" @default.
• W4311495621 title "Changes in the use of glucose‐lowering drugs: A Danish nationwide study" @default.
• W4311495621 cites W1932640386 @default.
• W4311495621 cites W1978670003 @default.
• W4311495621 cites W2026480246 @default.
• W4311495621 cites W2052954071 @default.
• W4311495621 cites W2151278054 @default.
• W4311495621 cites W2340743444 @default.
• W4311495621 cites W2399659685 @default.
• W4311495621 cites W2513040800 @default.
• W4311495621 cites W2753945370 @default.
• W4311495621 cites W2820285780 @default.
• W4311495621 cites W2916296804 @default.
• W4311495621 cites W2972605348 @default.
• W4311495621 cites W2974260792 @default.
• W4311495621 cites W3030652212 @default.
• W4311495621 cites W3043001187 @default.
• W4311495621 cites W3088173406 @default.
• W4311495621 cites W3096975943 @default.
• W4311495621 cites W3122226502 @default.
• W4311495621 cites W3130307224 @default.
• W4311495621 cites W3135449041 @default.
• W4311495621 cites W3149541685 @default.
• W4311495621 cites W3174878740 @default.
• W4311495621 cites W3185967843 @default.
• W4311495621 cites W3190801097 @default.
• W4311495621 cites W3195404919 @default.
• W4311495621 cites W4200439235 @default.
• W4311495621 cites W4205805562 @default.
• W4311495621 cites W4283362961 @default.
• W4311495621 cites W4296802076 @default.
• W4311495621 cites W4303857052 @default.
• W4311495621 cites W4308711092 @default.
• W4311495621 doi "https://doi.org/10.1111/dom.14947" @default.
• W4311495621 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36514856" @default.
• W4311495621 hasPublicationYear "2023" @default.
• W4311495621 type Work @default.
• W4311495621 citedByCount "6" @default.
• W4311495621 countsByYear W43114956212023 @default.
• W4311495621 crossrefType "journal-article" @default.
• W4311495621 hasAuthorship W4311495621A5004120950 @default.
• W4311495621 hasAuthorship W4311495621A5019863081 @default.
• W4311495621 hasAuthorship W4311495621A5048966021 @default.
• W4311495621 hasAuthorship W4311495621A5059577837 @default.
• W4311495621 hasAuthorship W4311495621A5072859924 @default.
• W4311495621 hasBestOaLocation W43114956211 @default.
• W4311495621 hasConcept C126322002 @default.
• W4311495621 hasConcept C134018914 @default.
• W4311495621 hasConcept C138885662 @default.
• W4311495621 hasConcept C164622146 @default.
• W4311495621 hasConcept C2777180221 @default.
• W4311495621 hasConcept C2779306644 @default.
• W4311495621 hasConcept C2780035454 @default.
• W4311495621 hasConcept C2780323712 @default.
• W4311495621 hasConcept C2908647359 @default.
• W4311495621 hasConcept C41895202 @default.
• W4311495621 hasConcept C555293320 @default.
• W4311495621 hasConcept C71924100 @default.
• W4311495621 hasConcept C98274493 @default.
• W4311495621 hasConcept C99454951 @default.
• W4311495621 hasConceptScore W4311495621C126322002 @default.
• W4311495621 hasConceptScore W4311495621C134018914 @default.
• W4311495621 hasConceptScore W4311495621C138885662 @default.
• W4311495621 hasConceptScore W4311495621C164622146 @default.
• W4311495621 hasConceptScore W4311495621C2777180221 @default.
• W4311495621 hasConceptScore W4311495621C2779306644 @default.
• W4311495621 hasConceptScore W4311495621C2780035454 @default.
• W4311495621 hasConceptScore W4311495621C2780323712 @default.
• W4311495621 hasConceptScore W4311495621C2908647359 @default.
• W4311495621 hasConceptScore W4311495621C41895202 @default.
• W4311495621 hasConceptScore W4311495621C555293320 @default.
• W4311495621 hasConceptScore W4311495621C71924100 @default.
• W4311495621 hasConceptScore W4311495621C98274493 @default.
• W4311495621 hasConceptScore W4311495621C99454951 @default.
• W4311495621 hasIssue "4" @default.
• W4311495621 hasLocation W43114956211 @default.
• W4311495621 hasLocation W43114956212 @default.
• W4311495621 hasOpenAccess W4311495621 @default.
• W4311495621 hasPrimaryLocation W43114956211 @default.
• W4311495621 hasRelatedWork W1983641721 @default.
• W4311495621 hasRelatedWork W1995945960 @default.
• W4311495621 hasRelatedWork W2005084305 @default.
• W4311495621 hasRelatedWork W2026226896 @default.
• W4311495621 hasRelatedWork W2033313326 @default.
• W4311495621 hasRelatedWork W2066345847 @default.
• W4311495621 hasRelatedWork W2089387278 @default.
• W4311495621 hasRelatedWork W2095179743 @default.
• W4311495621 hasRelatedWork W2130904138 @default.
• W4311495621 hasRelatedWork W2744240433 @default.
• W4311495621 hasVolume "25" @default.

• next